Search results for "epidermolysis bullosa"

showing 10 items of 22 documents

Ectopic expression of desmin in the epidermis of transgenic mice permits development of a normal epidermis.

2002

Cell architecture is largely based on the interaction of cytoskeletal proteins, which include intermediate filaments (IF), microfilaments, microtubules, as well as their type-specific membrane-attachment structures and associated proteins. In order to further our understanding of IF proteins and to address the fundamental issue whether different IF perform unique functions in different tissues, we expressed a desmin transgene in the basal epidermis of mice. Ectopic expression of desmin led to the formation of an additional, keratin-independent IF cytoskeleton and did not interfere with the keratin-desmosome interaction. We show that ectopic expression of a type III IF protein in basal kerat…

KeratinocytesCancer ResearchCellular differentiationMice Transgenicmacromolecular substancesBiologyDesminMiceKeratinmedicineAnimalsHumansIntermediate filamentCytoskeletonMolecular Biologychemistry.chemical_classificationEpidermis (botany)Keratin-14Cell BiologyImmunohistochemistryCell biologyDisease Models Animalmedicine.anatomical_structurePhenotypechemistryEpidermolysis Bullosa SimplexImmunologyKeratinsEctopic expressionDesminEpidermisKeratinocyteDevelopmental BiologyDifferentiation; research in biological diversity
researchProduct

Plectin-related scapuloperoneal myopathy with treatment-responsive myasthenic syndrome

2020

AdultMalePathologymedicine.medical_specialtyHistologymyasthenic syndromeMuskel- und KnochenstoffwechselPathology and Forensic MedicineEpidermolysis bullosa simplexAdrenergic AgentsPhysiology (medical)medicineHumansMuscular dystrophyFrameshift MutationEphedrineMyasthenic Syndromes Congenitalbusiness.industryPlectin-relatedPlectinmedicine.diseaseScapuloperoneal myopathyMuscular Dystrophy Emery-Dreifusstreatment-responsiveNeurologyPlectinNeurology (clinical)business
researchProduct

Control Of Organ Transplant-Associated Graft-versus-Host Disease By Activated Host Lymphocyte Infusions

2004

Background Prolonged persistence of donor-derived T cells after organ transplantation has been proposed to improve long-term allograft survival. However, surviving transplant-derived T cells are also able to mediate devastating graft-versus-host disease (GvHD). Currently, GvHD after organ transplantation is usually refractory to conventional therapy and the disease outcome fatal. Methods Graft-reactive host T cells were generated ex vivo from a patient suffering from a severe and refractory liver-transplant-associated GvHD. To control GvHD, activated alloreactive host T cells were repetitively retransferred into the patient (activated host lymphocyte infusion [aHLI]). Results Adoptive trans…

medicine.medical_specialtyAdoptive cell transferLymphocytemedicine.medical_treatmentGraft vs Host Diseasechemical and pharmacologic phenomenaLymphocyte ActivationImmunotherapy AdoptiveSeverity of Illness IndexOrgan transplantationBlood Transfusion AutologousmedicineHumansAgedTransplantationbusiness.industryImmunotherapymedicine.diseaseAdoptive TransferLiver TransplantationTransplantationsurgical procedures operativeGraft-versus-host diseasemedicine.anatomical_structureLymphocyte TransfusionImmunologyFemaleStem cellEpidermolysis BullosabusinessEx vivoTransplantation
researchProduct

Oral rehabilitation with dental implants in patients with recessive dystrophic epidermolysis bullosa : a retrospective study with 2-15 years of follo…

2019

Background Epidermolysis bullosa (EB) comprises a group of hereditary disorders characterized by mechanical fragility of the skin and mucous membranes, with the development of blisters and vesicles in response to minimum tissue friction. Recessive dystrophic epidermolysis bullosa (RDEB) with generalized involvement is the most common subtype in the oral cavity. The present study was carried out to investigate dental implant survival, peri-implant tissue condition, patient satisfaction, and the impact of treatment upon the quality of life of patients with RDEB rehabilitated with implants and full-arch implant-supported prostheses. Material and Methods Thirteen patients with RDEB underwent de…

Adultmedicine.medical_treatmentDentistry03 medical and health sciencesYoung Adult0302 clinical medicinePatient satisfactionmedicineMucositisMaxillaHumansJaw EdentulousDental Restoration FailureDental implantGeneral DentistrySurvival rateRetrospective StudiesDental ImplantsOral Medicine and Pathologybusiness.industryResearchDental prosthesisDental Implantation EndosseousEpidermolysis bullosa dystrophica030206 dentistryMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Epidermolysis Bullosa DystrophicaTreatment OutcomeOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASQuality of LifeSurgeryEpidermolysis bullosaImplantDental Prosthesis Implant-SupportedbusinessFollow-Up Studies
researchProduct

Implants in patients with oral manifestations of autoimmune or muco-cutaneous diseases – A systematic review

2018

Background To give an overview on implant survival rates in patients with oral manifestations of systemic autoimmune (oral Lichen planus (oLp), Pemphigus (Pe)), muco-cutaneous (Epidermolysis bullosa (EB)), autoimmune multisystemic rheumatic diseases (Sjögren´s syndrome (SjS), systemic Lupus erythematosus (sLE), or systemic Sclerosis (sSc)). Material and Methods Systematic literature review (PubMed/Medline, Embase) using MESH and search term combinations, published between 1980 and August 2018 in English language reporting on dental implant-prosthetic rehabilitation of patients with oLp, Pe, EB, SjS, sLE, sSc, study design, age, gender, follow-up period (≥ 12 months), implant survival rate. …

medicine.medical_specialtyDatabases FactualReviewScleroderma03 medical and health sciences0302 clinical medicinemedicineHumansLupus Erythematosus SystemicDental Restoration Failureskin and connective tissue diseasesGeneral DentistrySurvival rateDental ImplantsScleroderma SystemicLupus erythematosusintegumentary systembusiness.industryDental prosthesis030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Medically compromised patients in Dentistrymedicine.diseaseDermatologystomatognathic diseasesPemphigusSjogren's SyndromeTreatment OutcomeOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryOral lichen planusDental Prosthesis Implant-SupportedImplantEpidermolysis bullosaEpidermolysis BullosaMouth DiseasesbusinessPemphigusLichen Planus OralMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Focal adhesions are hotspots for keratin filament precursor formation

2006

Recent studies showed that keratin filament (KF) formation originates primarily from sites close to the actin-rich cell cortex. To further characterize these sites, we performed multicolor fluorescence imaging of living cells and found drastically increased KF assembly in regions of elevated actin turnover, i.e., in lamellipodia. Abundant KF precursors (KFPs) appeared within these areas at the distal tips of actin stress fibers, moving alongside the stress fibers until their integration into the peripheral KF network. The earliest KFPs were detected next to actin-anchoring focal adhesions (FAs) and were only seen after the establishment of FAs in emerging lamellipodia. Tight spatiotemporal …

TalinKeratin 14Intermediate Filamentsmacromolecular substancesBiologyTransfectionKeratin 18Cell LineFocal adhesionMiceReportStress FibersCell cortexMetalloproteinsAnimalsHumansRNA AntisensePseudopodiaCytoskeletonActinResearch ArticlesCell Line TransformedFocal AdhesionsKeratin FilamentKeratin-18Keratin-14Cell BiologyBridged Bicyclo Compounds HeterocyclicActinsZyxinCell biologyProtein TransportThiazolesBiochemistryEpidermolysis Bullosa SimplexMutationKeratinsThiazolidinesMarine ToxinsLamellipodiumPaxillinThe Journal of Cell Biology
researchProduct

Recognizable neonatal clinical features of aplasia cutis congenita

2020

Abstract Background Aplasia cutis congenita (ACC), classified in nine groups, is likely to be underreported, since milder isolated lesions in wellbeing newborns could often be undetected, and solitary lesions in the context of polymalformative syndromes could not always be reported. Regardless of form and cause, therapeutic options have in common the aim to restore the deficient mechanical and immunological cutaneous protection and to limit the risk of fluid leakage or rupture of the exposed organs. We aimed to review our institutional prevalence, comorbidities, treatment and outcome of newborns with ACC. Methods We conducted a retrospective study including all newborns affected by ACC and …

Male0301 basic medicinePediatricsmedicine.medical_specialtyMeningomyeloceleAbdominal compartment syndromeContext (language use)030105 genetics & heredityAplasia cutis congenita03 medical and health sciencesEctodermal DysplasiaPrevalenceHumansMedicineBody Weights and MeasuresRetrospective StudiesPregnancybusiness.industryResearchAbdominal wall defectInfant Newbornlcsh:RJ1-570Gestational agelcsh:PediatricsRetrospective cohort studyPrognosismedicine.diseaseSurvival RateAbdominal wall defectRetrospective study030104 developmental biologyItalyScalp defectFemaleApgar scoreJunctional epidermolysis bullosamedicine.symptombusiness
researchProduct

T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita

2016

AbstractT cells are key players in autoimmune diseases by supporting the production of autoantibodies. However, their contribution to the effector phase of antibody-mediated autoimmune dermatoses, i.e., tissue injury and inflammation of the skin, has not been investigated. In this paper, we demonstrate that T cells amplify the development of autoantibody-induced tissue injury in a prototypical, organ-specific autoimmune disease, namely epidermolysis bullosa acquisita (EBA) – characterized and caused by autoantibodies targeting type VII collagen. Specifically, we show that immune complex (IC)-induced inflammation depends on the presence of T cells – a process facilitated by T cell receptor (…

0301 basic medicineEpidermolysis bullosa acquisitamedicine.medical_specialtyCollagen Type VIINeutrophilsT-LymphocytesGene ExpressionMice NudeInflammationAntigen-Antibody ComplexCell CommunicationEpidermolysis Bullosa AcquisitaArticleMice03 medical and health sciencesCricetulus0302 clinical medicinemedicineAnimalsHumansAutoantibodiesSkinAutoimmune diseaseMice Inbred BALB CMultidisciplinarybusiness.industryT-cell receptorAutoantibodyAntibodies MonoclonalReceptors Antigen T-Cell gamma-deltamedicine.diseaseNatural killer T cellDermatologyImmune complexMice Inbred C57BLDisease Models Animal030104 developmental biologyLymphatic systemImmunoglobulin GImmunologyNatural Killer T-CellsLymph NodesRabbitsmedicine.symptombusinessSpleenSignal Transduction030215 immunologyScientific Reports
researchProduct

Placement of endosseous implants in patients with oral epidermolysis bullosa.

2000

Abstract Objective: To evaluate the feasibility of placing endosseous implants in patients with recessive dystrophic epidermolysis bullosa. This article reports on 4 patients subjected to follow-up. Study Design: Implants were placed in 4 cases. All patients have marked oral involvement, with devastating alterations in the soft and hard tissues in all cases. Results: A total of 15 implants (7 maxillary, 8 mandibular) were placed. All implants integrated successfully and have been restored. The average follow-up from implant placement was 2.5 years (range, 1-4). Conclusions: Our preliminary findings suggest that endosseous implants can be successfully placed and can provide support for prost…

AdultMalemedicine.medical_specialtyDentistryGenes RecessiveOral cavityRecessive dystrophic epidermolysis bullosamedicineHumansJaw EdentulousEndosseous implantsIn patientProspective StudiesGeneral Dentistrybusiness.industryDental prosthesisDental Implantation EndosseousMouth Mucosamedicine.diseaseDenture OverlaySurgeryEpidermolysis Bullosa DystrophicaImplant placementTreatment OutcomeOtorhinolaryngologyDental Care for Chronically IllSurgeryFemaleEpidermolysis bullosaImplantDental Prosthesis Implant-SupportedOral SurgerybusinessMouth DiseasesOral surgery, oral medicine, oral pathology, oral radiology, and endodontics
researchProduct

Dystrophic epidermolysis bullosa: oral findings and problems.

2006

Dystrophic epidermolysis bullosa (DEB) is one of the three major types of epidermolysis bullosa (EB), an inherited cutaneous disease with blister formation following minor trauma. A subtype of DEB is recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type (RDEB-HS), where marked scarring leads to deformities of extremities. In RDEB-HS the mucous membranes may also be involved and form adhesions with ankyloglossia and microstomia. Oral hygiene is difficult. A 7-year-old boy with RDEB-HS was brought to the Johannes Gutenberg University dental clinic with dental pain. He had multiple carious lesions, poor oral hygiene and gingivitis. Because he was noncompliant and had microstomia, …

MalePit and Fissure SealantsToothbrushingmedicine.medical_specialtyMouthwashesDiseaseDental CariesOral hygieneGingivitismedicineHumansChildDental Restoration PermanentGeneral Dentistrybusiness.industryMicrostomiaDental Care for DisabledChlorhexidineChlorhexidineEpidermolysis bullosa dystrophicamedicine.diseaseDental Care for DisabledDermatologyEpidermolysis Bullosa Dystrophicastomatognathic diseasesTooth ExtractionAnti-Infective Agents LocalEpidermolysis bullosamedicine.symptombusinessmedicine.drugFollow-Up StudiesSpecial care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
researchProduct